Mycovia Pharmaceuticals

Developer of small molecule based therapeutics for the treatment of recurrent vulvovaginal candidiasis

placeDurham, North Carolina, United States calendar_todayFounded 2018 groups61 employees language mycovia.com

Social engagement

Social engagement: 3.6K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Private equity150%
Other / undisclosed150%

Recent activity

18 May 2026
Event
Regulatory Affairs Professionals Society Panel Discussion: From Classroom to Career: Bridging the Gap in Clinical Research and Regulatory Workforce Development
Coming soon